Clinician Strategies and Resources II: Bridging Primary Care and Oncology in AYA Cancer Survivorship (Social Worker)

Credit Available: APA, ASWB, CME, NCPD

 

Enroll in this Course

FREE

access until April 10, 2027 12:00 am

 

Enroll Now

Activity Description

This recorded webinar featured a panel of subject matter experts, explores the unique challenges and opportunities to support adolescent and young adult (AYA) survivors of cancer. The role of primary care clinicians in managing long-term follow up care, strategies to strengthen communication between oncology and primary care teams, and resources to support AYA survivors, their caregivers, and healthcare professionals will be discussed, with opportunities for input from the audience.

Time to Complete Activity: 1.0 hour

This course is available from:

October 10, 2025 until April 9, 2027

Course Instructors

Rebecca Eary, DO, MPH Speaker

Assistant Professor, Department of Family and Community Medicine, UT Southwestern Medical School, Medical Director, Primary Care Cancer Survivorship Clinic and the After Cancer Experience (ACE), Adult Program for Adolescent and Childhood Cancer Survivors, Dallas, TX

Melody Griffith, MSW, LMSW Speaker

Outpatient Adolescent and Young Adult (AYA), Oncology Social Worker Instructor in Social Work, Mayo Clinic College of Medicine and Science Section of Social Work Mayo Clinic, Arizona, Phoenix, AZ

Tricia Hernandez, MS Speaker

Director, Community Engagement, Blood Cancer United, Washington, DC

Maggie Rogers, MPH Moderator

Director, Pediatric, Adolescent and Young Adult Cancer Support, The American Cancer Society, Raleigh, NC

Allison Rosenthal, DO Speaker

Medical Director, AYA Cancer Program, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic Arizona, Phoenix, AZ

Samantha Siegel, MD  Speaker

Onco-PCP and Survivorship Clinician, Director of Cancer Survivorship, Kaiser San Francisco, Co-Director PCP-ONC CARES Program,  San Francisco, CA

Target Audience

This activity is intended for hematologists/oncologists, advanced practice providers, nurses, psychologists, social workers, and other healthcare professionals involved in the care of adolescent and young adult (AYA) survivors of cancer.

Learning Objectives
After completing this activity, the participant should be better able to:

• • Describe the unique survivorship challenges AYA patients face during care transitions and integration with primary care
  • Explain the important role of primary care clinicians in delivering long-term follow up care for AYA cancer survivors
  • Apply communication and care coordination strategies to strengthen the relationship between oncology and primary care teams
  • Access tools and resources to support AYA cancer survivors, their caregivers, and healthcare professionals

Accreditation, Credit and Support

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute Inc and Blood Cancer United. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Medical Learning Institute Inc (MLI) designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologist Continuing Education

Medical Learning Institute Inc designates this activity for 1.0 CE credits. No partial credit will be awarded.

For Psychologists, CE credit is awarded only for actual instructional time. Full attendance is required for all CE activities; variable credit for partial attendance will not be awarded.

Registered Nursing Credit Designation

Approval for nurses has been obtained by the National Office of Blood Cancer United under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

Social Worker Continuing Education

As a Jointly Accredited Organization, Medical Learning Institute Inc (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 Clinical Social Work continuing education credit.

Interprofessional Continuing Education Credit

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Providers

This activity is provided by Blood Cancer United and Medical Learning Institute Inc, in collaboration with The American Cancer Society.

Support Statement

There is no commercial support associated with this CE activity.

Disclosure of Conflicts of Interest Policy

Medical Learning Institute Inc and Blood Cancer United, are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI and Blood Cancer United require faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI and Blood Cancer United policy. These disclosures will be provided to learners prior to the start of the CE activity.

Faculty Disclosures

Rebecca Eary, DO, MPH, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Tricia Hernandez, MS, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Maggie Rogers, MPH, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Melody Griffith, MSW, LMSW, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Allison Rosenthal, DO, has a financial interest/relationship or affiliation in the form of:
Speakers’ Bureau: Curio Science, RMEI Medical Education, LLC

Samantha Siegel, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Medical Learning Institute Inc and Blood Cancer United do not have any relevant financial relationships to disclose with ineligible companies unless listed below.

Lauren Berger, MPH, has a financial interest/relationship or affiliation in the form of:
Stock Ownership with Bristol Myers Squibb, Gilead Sciences, Inc., Merck & Co., Inc., Organon & Co., Pfizer Inc., and Viatris Inc.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the accredited CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

About this Activity

Medical Learning Institute Inc and Blood Cancer United are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute Inc and Blood Cancer United.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute Inc or any of its partners, providers, and/or supporters.

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated.

If you have questions regarding your certificate, please contact Nicole Dane via email at ndane@kimeglobal.com.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.